What is the role of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations in the pathology—including, as soluble, circulating mediators—of renal disease in FD?

What is the role of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations in the pathology—including, as soluble, circulating mediators—of renal disease in FD?

What is the role of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations in the pathology - including, as soluble, circulating mediators - of renal disease in FD? And what are the common pathobiological features in the nephropathy of FD and that found in diabetic kidney disease? 


Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

Alberto Ortiz, MD

Alberto Ortiz, MD

Chief of Nephrology and Hypertension
Renal Unit, IIS-Fundacio?n Jime?nez Di?az
Universidad Auto?noma de Madrid, FRIAT
Madrid, Spain